Home › Funds › OGOREK ANTHONY JOSEPH /NY/ /ADV › DOCT
OGOREK ANTHONY JOSEPH /NY/ /ADV position in DOCT
FIRST TR EXCHNG TRADED FD VI
OGOREK ANTHONY JOSEPH /NY/ /ADV reported holding 283,355 shares of DOCT (FIRST TR EXCHNG TRADED FD VI) in its Q3 2026 13F filing — a position valued at US$13.6M, representing 3.38% of its reported portfolio and ranking #9 among its reported holdings. OGOREK ANTHONY JOSEPH /NY/ /ADV has disclosed DOCT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How OGOREK ANTHONY JOSEPH /NY/ /ADV's DOCT position evolved
OGOREK ANTHONY JOSEPH /NY/ /ADV first disclosed a stake in DOCT in Q4 2024 at 3,553 shares (US$139K). The position peaked in Q3 2026 at 283,355 shares, worth US$13.6M. Across 8 filings, OGOREK ANTHONY JOSEPH /NY/ /ADV increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 283,355 shares valued at US$13.6M. Notable position changes include a 8625% increase in Q1 2025 (shares rose 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 3.55K | $139.00K | New |
| Q1 2025 | 309.98K | $11.89M | Add |
| Q2 2025 | 307.09K | $12.61M | Reduce |
| Q3 2025 | 303.52K | $13.11M | Reduce |
| Q4 2025 | 301.24K | $13.34M | Reduce |
| Q1 2026 | 286.18K | $12.43M | Reduce |
| Q2 2026 | 284.39K | $13.28M | Reduce |
| Q3 2026 | 283.36K | $13.61M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DOCT and 13F data
DOCT (FIRST TR EXCHNG TRADED FD VI) is a company whose sector is not yet classified in our data. 31 other funds we track also report a position in DOCT — the largest reported positions include REAP Financial Group, LLC (US$9.8M), Wood Tarver Financial Group, LLC (US$8.3M), Per Stirling Capital Management, LLC. (US$6.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DOCT
- REAP Financial Group, LLC 203.71K sh · $9.79M · Q3 2026
- Wood Tarver Financial Group, LLC 176.85K sh · $8.26M · Q2 2026
- Per Stirling Capital Management, LLC. 143.06K sh · $6.87M · Q3 2026
- LCNB CORP 114.17K sh · $5.49M · Q3 2026
- WINNACLE WEALTH LLC 96.05K sh · $4.61M · Q3 2026
- Foguth Wealth Management, LLC. 87.03K sh · $4.20M · Q3 2026
- Commonwealth Financial Services, LLC 46.50K sh · $2.23M · Q3 2026
- Castleview Partners, LLC 32.36K sh · $1.55M · Q3 2026
More on OGOREK ANTHONY JOSEPH /NY/ /ADV
FAQ
How long has OGOREK ANTHONY JOSEPH /NY/ /ADV held DOCT?
OGOREK ANTHONY JOSEPH /NY/ /ADV has disclosed DOCT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is OGOREK ANTHONY JOSEPH /NY/ /ADV's current position in DOCT?
As of Q3 2026, OGOREK ANTHONY JOSEPH /NY/ /ADV holds 283.36K shares of DOCT (FIRST TR EXCHNG TRADED FD VI), valued at $13.61M, representing 3.38% of its reported portfolio and ranking #9.
Has OGOREK ANTHONY JOSEPH /NY/ /ADV been buying or selling DOCT?
In the latest 13F filing (Q3 2026), OGOREK ANTHONY JOSEPH /NY/ /ADV held unchanged its position in DOCT. The position peaked in Q3 2026 at 283.36K shares.
Which other funds hold DOCT?
Other major institutional holders of DOCT include REAP Financial Group, LLC, Wood Tarver Financial Group, LLC, Per Stirling Capital Management, LLC., among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.